Phase II Clinical Trial of Trametinib and Low-Dose Dabrafenib in Advanced, Previously Treated BRAF V600 /NRAS Q61 Wild-Type Melanoma (TraMel-WT).
Saved in:
| Title: | Phase II Clinical Trial of Trametinib and Low-Dose Dabrafenib in Advanced, Previously Treated BRAF V600 /NRAS Q61 Wild-Type Melanoma (TraMel-WT). |
|---|---|
| Authors: | Awada, Gil1 (AUTHOR) Gil.Awada@uzbrussel.be, Dirven, Iris1 (AUTHOR), Schwarze, Julia Katharina1 (AUTHOR), Tijtgat, Jens1 (AUTHOR), Fasolino, Giuseppe2 (AUTHOR), Kockx, Mark3 (AUTHOR), Neyns, Bart1 (AUTHOR) |
| Source: | JCO Precision Oncology. 12/1/2024, Vol. 8, p1-16. 16p. |
| Database: | Academic Search Ultimate |
| ISSN: | 24734284 |
|---|---|
| DOI: | 10.1200/PO.23.00493 |
